X-Linked Hypophosphatemia

Disease Overview

X-Linked Hypophosphatemia (XLH) is a rare genetic disorder characterized by impaired phosphate metabolism, resulting in low blood phosphate levels and abnormal bone development. The condition leads to rickets in children and osteomalacia in adults, causing skeletal deformities and potential growth complications.

Disease Category

Genetic disorder
Metabolic bone disease
X-linked inherited condition
Rare genetic disorder

Synonyms

X-Linked Vitamin D-Resistant Rickets
Hypophosphatemic Rickets
Familial Hypophosphatemic Rickets

Signs & Symptoms

Bone pain and muscle weakness
Bowed legs and short stature
Delayed growth
Rickets in children
Osteomalacia in adults
Dental abnormalities
Spontaneous dental abscesses
Enlarged skull
Joint pain and stiffness
Reduced bone mineralization
Increased risk of fractures

Causes

Mutations in the PHEX gene located on the X chromosome
Dysregulation of phosphate homeostasis
Increased levels of Fibroblast Growth Factor 23 (FGF23)
Impaired renal phosphate reabsorption
Genetic inheritance pattern: X-linked dominant

Affected Populations

Prevalence: 1 in 20,000 to 1 in 60,000 live births
Affects both males and females
Males typically experience more severe symptoms
Onset usually occurs in early childhood
Genetic transmission primarily through maternal inheritance

Disorders with Similar Symptoms

Autosomal Dominant Hypophosphatemic Rickets (ADHR)
Autosomal Recessive Hypophosphatemic Rickets (ARHR)
Fanconi Syndrome
Hereditary Hypophosphatemic Rickets with Hypercalciuria (HHRH)
Tumor-induced osteomalacia

Diagnosis

Comprehensive clinical evaluation
Detailed family medical history
Biochemical tests
- Low serum phosphate levels
- High urinary phosphate excretion
- Elevated alkaline phosphatase
Genetic testing for PHEX gene mutations
Radiographic imaging
Bone density scans
Dental examinations

Standard Therapies

Oral phosphate supplements
Active vitamin D derivatives (calcitriol, alfacalcidol)
Burosumab (monoclonal antibody targeting FGF23)
Growth hormone therapy
Orthopedic interventions
Dental treatments
Physical therapy
Nutritional counseling

Clinical Trials and Studies

Ongoing research at major medical centers
Clinicaltrials.gov listings for XLH
Investigations into novel genetic therapies
Long-term treatment outcome studies
Emerging targeted molecular treatments

References

National Institutes of Health (NIH)
Genetic and Rare Diseases Information Center
International Bone and Mineral Society
Journal of Clinical Endocrinology & Metabolism

Programs & Resources

XLH Network Inc.
National Organization for Rare Disorders (NORD)
Global Genes
NIH Genetic and Rare Diseases Information Center
Pediatric Endocrine Society
Rare Bone Disease Patient Network

Complete Report

X-Linked Hypophosphatemia is a complex genetic disorder affecting phosphate metabolism, causing significant skeletal and dental complications. Comprehensive management requires multidisciplinary care, genetic counseling, and ongoing medical monitoring to optimize patient outcomes and quality of life.